Tan Hui-Leng, Chawla Jasneek
Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK
Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia.
Eur Respir Rev. 2024 Dec 18;33(174). doi: 10.1183/16000617.0154-2024. Print 2024 Oct.
Worldwide, there has been a dramatic increase in the use of paediatric home mechanical ventilation (HMV). In this review, we examine this rapid evolution in clinical practice through the prism of two distinct groups of children: those with neurodisability/medical complexity and patients with neuromuscular disease. We illustrate the changes in service provision for these two groups that are driven by a recognition that early intervention with HMV can enhance quality of life for these children and may complement the beneficial effects of novel disease-modifying medications to improve survival. Alongside this, we highlight the importance of balancing patient expectations with clinical need and discuss the ethical challenges that may be encountered when delivering HMV to this increasing population of children.
在全球范围内,儿科家庭机械通气(HMV)的使用量急剧增加。在本综述中,我们通过两类不同儿童群体的视角审视了这一临床实践中的快速演变:患有神经残疾/病情复杂的儿童以及患有神经肌肉疾病的患者。我们阐述了针对这两类群体服务提供方面的变化,这些变化是由以下认识推动的:早期使用HMV进行干预可提高这些儿童的生活质量,并且可能补充新型疾病修正药物的有益效果以提高生存率。与此同时,我们强调了平衡患者期望与临床需求的重要性,并讨论了在为越来越多的儿童提供HMV时可能遇到的伦理挑战。